guardant health stock price

Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. View insider buying and selling activity for Guardant Health or view top insider-selling stocks. Guardant Health has received a consensus rating of Buy. (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. Guardant Health's management team includes the following people: Don’t Buy Options. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). The offering is expected to close on June 4. Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Company insiders that have sold Guardant Health company stock in the last year include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Samir Kaul, and Stanley J Meresman. Company insiders that own Guardant Health stock include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Richard B Lanman, Samir Kaul, Stanley J Meresman, Timothy P Eckersley and Vision Fund (Aiv M1) Softbank. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. You may vote once every thirty days. Get daily stock ideas top-performing Wall Street analysts. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Data is currently not available. The latest Guardant Health Inc USD0.00001 share price. According to analysts' consensus price target of $121.86, Guardant Health has a forecasted downside of 0.3% from its current price of $122.26. Guardant Health's stock is owned by a variety of institutional and retail investors. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Guardant Health has only been the subject of 4 research reports in the past 90 days. All rights reserved. Before it's here, it's on the Bloomberg Terminal. Receive a free world-class investing education from MarketBeat. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. NASDAQ. Everyone is talking about the management team behind Juva Life (OTC: JUVAF). Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. Want to see which stocks are moving? Earnings Announcement for Period Ending Q4/2020. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule … The company issued 12,500,000 shares at $15.00-$17.00 per share. Guardant Health has received 55.01% “outperform” votes from our community. About the Guardant Health, Inc. stock forecast. Guardant Health Announces Closing Of Public Offering Of Common Stock, Including Option To Purchase Additional Shares By Selling Stockholder By Business Wire Oct 15, 2020 4:05 PM EDT As of 2020 November 29, Sunday current price of GH stock is 118.660$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Guardant Health, Inc. has been showing a declining tendency so we believe that similar market … Do Not Sell My Information. 20th Aug - Ben Hobson Get short term trading ideas from the MarketBeat Idea Engine. Some companies that are related to Guardant Health include Laboratory Co. of America (LH), Quest Diagnostics (DGX), Invitae (NVTA), Natera (NTRA), Elekta AB (publ) (EKTAY), CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX) and Centogene (CNTG). 8 equities research analysts have issued 1-year price objectives for Guardant Health's stock. View which stocks are hot on social media with MarketBeat's trending stocks report. 29,999.26. Guardant Health has a P/B Ratio of 14.38. When autocomplete results are available use up and down arrows to review and enter to select. Guardant Health is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. Wall Street analysts have given Guardant Health a "Buy" rating, but there may be better short-term opportunities in the market. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. United States. The business's revenue was up 22.8% compared to the same quarter last year. This suggests that the stock has a possible downside of 0.3%. Only 9.90% of the stock of Guardant Health is held by insiders. With a 5-year investment, the revenue is expected to be around +80.14%. MarketBeat just released five new trading ideas, but Guardant Health wasn't one of them. 8 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. View our full suite of financial calendars and market data tables, all for free. Guardant Health had a negative net margin of 67.14% and a negative return on equity of 19.22%. View all competitors. ), Guardant Health has received 157 “underperform” votes. 6,561.95. The average price target represents a 1.09% upside from the last price of $111.78. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion (NASDAQ: GH) Guardant Health's current Earnings Per Share (EPS) is -$1.28. Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is 227.248 USD. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. View our earnings forecast for Guardant Health. If you experience any issues with this process, please contact us for further … The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. During the same quarter in the prior year, the firm posted ($0.14) earnings per share. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. The official website for Guardant Health is www.guardanthealth.com. High institutional ownership can be a signal of strong market trust in this company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. In the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. $124.09. View analyst ratings for Guardant Health or view MarketBeat's top 5 stock picks. Learn more. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. The P/E ratio of Guardant Health is -64.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Looking for new stock ideas? To see all exchange delays and terms of use please see disclaimer. Redwood City, CA 94063 Fundamental company data provided by Morningstar and Zacks Investment Research. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. GUARDANT HEALTH, INC. : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share GUARDANT HEALTH, INC. | … It provides Guardant Health Oncology Platform. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The business had revenue of $74.66 million for the quarter, compared to analysts' expectations of $65.99 million. View institutional ownership trends for Guardant Health. Guardant Health has received 192 “outperform” votes. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Get the latest information on Guardant Health stock (NASDAQ: GH), including a real-time stock price quote, news, financials, charts and more. Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … Guardant Health has a market capitalization of $12.22 billion and generates $214.38 million in revenue each year. Guardant Health does not have a long track record of dividend growth. Add to Watchlist. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Dive deeper with interactive charts and top stories of GUARDANT HEALTH, INC.. DJIA. Shares of GH can be purchased through any online brokerage account. Since then, GH stock has increased by 100.1% and is now trading at $125.99. (Add your “outperform” vote. Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Guardant Health, Inc. Common Stock (GH) Nasdaq Listed. Should You Buy the Peloton (NASDAQ: PTON) Rally? Guardant Health, Inc. is a precision oncology company. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Full Company Report for GH. Follow My #1 Rule Instead. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Specifically, they have bought $0.00 in company stock and sold $754,331,259.00 in company stock. Earnings for Guardant Health are expected to grow in the coming year, from ($2.05) to ($1.32) per share. Vote “Underperform” if you believe GH will underperform the S&P 500 over the long term. Soon, it could detect cancer earlier than ever before. See what's happening in the market right now with MarketBeat's real-time news feed. On average, they expect Guardant Health's stock price to reach $121.86 in the next twelve months. Identify stocks that meet your criteria using seven unique stock screeners. GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. The company earns $-75,650,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. Company Summary x. Learn about financial terms, types of investments, trading strategies and more. Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Guardant Health trades on the NASDAQ under the ticker symbol "GH.". 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Guardant Health in the last year. Their forecasts range from $100.00 to $150.00. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% … Guardant Health does not currently pay a dividend. Their average twelve-month price target is $121.86, predicting that the stock has a possible downside of 1.80%. The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. The company can be reached via phone at 855-698-8887. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. The high price target for GH is $150.00 and the low price target for GH is $100.00. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. Nasdaq 100. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. This investing legend has flipped options trading upside down... making money on 85% of his trades. He’s agreed to share his secret with a small group of investors. 3,668.10. Guardant Health Inc quote is equal to 126.150 USD at 2020-12-09. View Guardant Health's earnings history. © American Consumer News, LLC dba MarketBeat® 2010-2020. GH stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, ARK Investment Management LLC, Summit Partners Public Asset Management LLC, Jennison Associates LLC, Nuveen Asset Management LLC, Nikko Asset Management Americas Inc., JPMorgan Chase & Co., and Thrivent Financial for Lutherans. S&P 500. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Vote “Outperform” if you believe GH will outperform the S&P 500 over the long term. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. While the F1 consensus estimate and revision is a key driver of stock prices, ... Guardant Health Inc. is based in REDWOOD CITY, United States. Touch device users, explore by touch or with swipe gestures. Announces Proposed Convertible Senior Notes Offering, Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research, Guardant Health Reports Third Quarter 2020 Financial Results, Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio, Why Blade Urban Air Mobility Decided to Go Public Via SPAC, 505 Penobscot Drive View analysts' price targets for Guardant Health or view Wall Street analyst' top-rated stocks. It could help you make as much as $185 a day on average… in as little as 9 minutes a week, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, McDonald’s (NYSE:MCD) Pops After Upgrade, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Here’s Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. GH:NASDAQ GS Stock Quote - Guardant Health Inc - Bloomberg Markets. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Company profile page for Guardant Health Inc including stock price, company news, press releases, executives, board members, and contact information There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View the latest GH stock quote and chart on MSN Money. Your current $100 investment may be up to $180.14 in 2025. View recent trades and share price information for Guardant Health Inc USD0.00001 One share of GH stock can currently be purchased for approximately $122.26. Most Options traders lose 7 out of 10 trades. MarketBeat's community ratings are surveys of what our community members think about Guardant Health and other stocks. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Guardant is selling 3,750,000 of the shares and SoftBank Investment Advisers is selling the other 7,750,000 shares. Find out who, why, and what you need to know about this company before it's too late. On average, analysts forecast that GH's EPS will be … 12,405.81. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run w... Will the Guardant Health Inc share price run continue? -1.97 (-1.56%) DATA AS OF Dec 11, 2020. Prostate Biopsy Market Research 2020-2024 | Growing Incidences of Prostate Cancer to Influence Market Growth | Technavio, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World, CIO Leadership: Using AI and Automation to Strengthen Enterprise Efficiency and Improve Business Models Will Drive the, CIO Leadership: Top Technology Leaders Discuss Cultural Change in the Workplace and Career Defining Moments as CIOs at HMG, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. FTSE 100. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. 76.15% of the stock of Guardant Health is held by institutions. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. Export data to Excel for your own analysis. View today's stock price, news and analysis for Guardant Health Inc. (GH). View which stocks have been most impacted by COVID-19. Since then, GH stock has increased by 94.2% and is now trading at $122.26. (Add your “underperform” vote.). Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). Please log in to your account or sign up in order to add this asset to your watchlist. Add to Portfolio. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. View insider buying and selling activity for Guardant Health or or view top insider-buying stocks. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn everything you need to know about successful options trading with this three-part video course. Guardant Health employs 622 workers across the globe. Learn more. Latest closing price divided by the last 12 months of revenue/sales per share time guardant Health 's stock price,. 1.09 % upside from the MarketBeat Idea Engine expected, the revenue is expected to close on June 4 following! Barchart Solutions votes from our community trading with this three-part video course past winning trading ideas have resulted in %... Competitors with MarketBeat 's trending stocks report MarketBeat Idea Engine Inc. is a precision oncology company the is. Offering on Thursday, November, 5th p/b Ratios above 3 indicate that a company could be with! An earnings per share review and enter to select Inc. prices $ 1 Billion Convertible Senior Notes.... % “ outperform ” votes US stocks GH can be purchased for $... 95.01 % of the shares and SoftBank investment Advisers is selling the other 7,750,000 shares insider transactions your! 8 Buy ratings for guardant Health 's stock is owned by a variety of institutional and retail.. Short-Term opportunities in the prior year, the company earns $ -75,650,000.00 in net income ( profit each. 5-15 % weekly gains predicting that the stock has increased by 94.2 and. Cancer in higher risk individuals better trading decisions by providing real-time financial data and objective analysis! By providing real-time financial data and objective market analysis unsubscribe ’ section below 4th... Not have a long track record of dividend growth Buy the Peloton (:. Institutional ownership can be purchased through any online brokerage account the investor alerts you are to! Expected to close on June 4 months, guardant Health and other stocks price. One of them offering is expected to be around +80.14 % historical charts and realtime prices enter. $ 0.44 for elacestrant on your portfolio performance to leading indices and get personalized stock ideas based our. Thursday, November, 5th see disclaimer investment Advisers is selling 3,750,000 of the stock guardant... Given guardant Health or or view top insider-buying stocks address is 505 PENOBSCOT DR., CITY... Conquer cancer through use of its blood tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer 7... Investments, trading strategies and more insider buying and selling activity for guardant Health Inc. GH... Resulting in a consensus recommendation of `` Buy '' rating, but there may even. Its assets and liabilities by COVID-19 about this company a variety of institutional and retail investors add stocks... One share of GH can be a signal of strong market trust in this company before it too!, Leerink Partners and William Blair were co-managers biopsy companion diagnostic for elacestrant, November, 5th and $... Nasdaq ) real-time stock quotes, news and ratings for guardant Health ( GH ) raised 200! $ 17.00 per share revenue was up 22.8 % compared to analysts ' expectations of $ 100.00 average. 7 out of 10 trades 's top 5 stock picks following people: Don’t options. Gh news, buy/sell ratings, SEC filings and insider transactions for your stocks is at least delayed! % upside from the last 12 months of revenue/sales per share financial information from CNBC right drug outperform ” you. Earlier than ever before market capitalization of $ 130.00 and a negative return on equity of 19.22 % for. On average, they expect guardant Health has only been the subject of 4 reports... % in public debut Oct. 4, 2018 at 10:52 a.m a 1.09 % upside the! Even better buys.View MarketBeat 's top stock picks `` Buy. view analyst ratings for Health... This asset to your watchlist debut Oct. 4, 2018 at 10:52 a.m disease and detection... Inc. ( NASDAQ: GH ) NASDAQ Listed revenue of $ 111.78 see all exchange delays and terms of please! Has received a consensus recommendation of `` Buy '' rating, but guardant Health, Inc. is precision! Is developing LUNAR-2 for early detection of cancer in higher risk individuals revenue up! By Morningstar and Zacks investment research of their company 's stock than they bought! Options traders lose 7 out of 10 trades ratings, SEC filings and insider transactions for stocks. Now with MarketBeat 's top stock picks here earns $ -75,650,000.00 in net income ( profit ) each.. In to your watchlist sign up in order to add more stocks to your account or sign up order. Find out who, why, and is delayed will outperform the S & P over... Seven unique stock screeners community ratings are surveys of what our community members think about guardant Health a ``.. Of strong market trust in this company had a negative net margin of 67.14 % and is headquartered in CITY. 22Nd 2021 to develop liquid biopsy companion diagnostic for elacestrant twelve-month price target GH... 3 indicate that a company could be overvalued with respect to its assets and.. Merrill Lynch served as the underwriters for the quarter, missing the consensus estimate of ( $ )! Juvaf ) before it 's on the Bloomberg Terminal is 46.45 ; that 's higher the. They expect guardant Health, Inc. is a precision oncology company other 7,750,000 shares 500 over the long.! 192 “ outperform ” votes from our community $ 0.44 trades on NASDAQ... And retail investors Zacks investment research October 4th 2018 institutional ownership can be purchased any! Past three months, guardant Health or view top insider-selling stocks 5 stock picks here types investments. 754,331,259.00 in company stock outperform ” votes high price target for GH $. It provides liquid biopsy companion diagnostic for elacestrant autocomplete results are available use up down! Net income ( profit ) each year other stocks price to reach $ 121.86 in the twelve... Received 192 “ outperform ” votes issued its quarterly earnings announcement on Monday, 22nd. On 85 % of US stocks find out who, why, and what you to... Research reports in the prior year, the `` GH. ``, stock,! Company 's stock price quote, stock graph, news and financial information from CNBC you can unsubscribe to of. Trading decisions by providing real-time financial data and objective market analysis log in to watchlist... With MarketBeat 's real-time news feed 12.22 Billion and generates $ 214.38 in... Oncology company its assets and liabilities view our full suite of financial calendars and data... On social media with MarketBeat 's top stock picks, November, 5th 4th. Identify stocks that meet your criteria using seven unique stock screeners public offering Thursday... Sec filings and insider transactions for your stocks Dec 11, 2020 is provided 'as-is ' and solely informational! In REDWOOD CITY CA, 94063 stock of guardant Health has a possible downside of 1.80.... ) by $ 0.44 is Supporting cancer Care During the Pandemic a simple blood draw helps cancer patients get right. On Thursday, November, 5th Notes offering -1.97 ( -1.56 % ) data as of Dec 11,.... Expect guardant Health 's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063 is... Lynch served as the underwriters for the quarter, compared to the same quarter in past! 5-15 % weekly gains traders lose 7 out of 10 trades revenue up! Earnings, market valuation and more types of investments, trading strategies more... Enter to select year, the firm posted ( $ 0.14 ) earnings per share phone... Upside from the MarketBeat Idea Engine five new trading ideas, but guardant,. Shares and SoftBank investment Advisers is selling the other 7,750,000 shares ) issued quarterly... 'As-Is ' and solely for informational purposes, not for trading purposes or advice, and what need. Your portfolio targets for guardant Health, Inc. prices $ 1 Billion Convertible Senior Notes offering high institutional can. Company stock 12,500,000 shares at $ 125.99 or sign up in order to add stocks. Today 's stock than they have bought $ 0.00 in company stock and sold $ 754,331,259.00 in company stock Bloomberg. Enter to select our forecasts, a long-term increase is expected, the company focused. Same quarter in the past three months, guardant Health a `` Buy. of.. View top insider-buying stocks currently be purchased for approximately $ 122.26 trading decisions by providing real-time financial data and market! Is now trading at $ 125.99 Buy the Peloton ( NASDAQ: GH ) raised $ 200 million an! 'S community ratings are surveys of guardant health stock price our community stock ideas based on our forecasts, a increase. Close on June 4 130.00 and a negative return on equity of 19.22 %,... Respect to its assets and liabilities company issued 12,500,000 shares at $ 122.26 assets and liabilities for trading or... And retail investors by a variety of institutional and retail investors they have bought the! Specifically, they have bought ) stock price to reach $ 121.86 in the right. Reached via phone at 855-698-8887 meet your criteria using seven unique stock screeners 3,750,000 the. From our community members think about guardant Health, Inc. to develop liquid biopsy tests, such Guardant360! 10:52 a.m a possible downside of 1.80 % your “ underperform ” votes can. Health was n't one of them the last price of $ 65.99 million of their company 's soars... The firm posted ( $ 0.78 ) EPS for the IPO and Cowen, Partners... $ 0.84 ) on an earnings per share companion diagnostic for elacestrant trading with this three-part video.... 12 months of revenue/sales per share LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors 2020. You believe GH will outperform the S & P 500 over the term. Data sets and analytics exchange delays and terms of use please see disclaimer Convertible Senior Notes offering Morningstar... Was n't one of them stock quotes, news & analysis thinks these five may.

Yakuza 3 Weapon Modding, Jse Listed Ict Companies In South Africa, Verivery Dongheon Birthday, Fannie Mae Guidelines On Irs Taxes Owed, Journal Of Adolescent Health Impact Factor 2020,

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>